Dr. James A. Fagin, originally from the University of Buenos Aires, Argentina, completed his residency at Hadassah University Hospital in Jerusalem before relocating to the United States. At MSKCC, Dr. Fagin has established himself as a foremost expert in the molecular genetics of thyroid cancer, contributing significantly to the development of targeted therapies. His groundbreaking research and numerous publications have earned him prestigious awards, including the Van Meter Award. Dr. Fagin is highly respected for his scientific achievements and his commitment to mentoring junior researchers and fellows in the field of endocrine oncology.
Education
- Medical School: University of Buenos Aires, Argentina
- Residency: Hadassah University Hospital, Jerusalem
- Board Certification: American Board of Internal Medicine (Endocrinology)
Awards
- Van Meter Award – American Thyroid Association
- Sidney H. Ingbar Distinguished Lectureship Award – Endocrine Society
- Distinguished Scientific Achievement Award – American Thyroid Association
Professional Memberships and Affiliation
- American Thyroid Association
- Endocrine Society
- American Association for Cancer Research
Clinical Experience
Dr. James A. Fagin has dedicated over 30 years to medical oncology with a focus on thyroid cancer at Memorial Sloan Kettering Cancer Center. His extensive clinical experience encompasses the molecular genetics of thyroid neoplasia and the application of targeted therapies for advanced thyroid carcinomas. Dr. Fagin is a leading authority in his field, adept at managing complex cases and advancing personalized treatment strategies that enhance patient survival and quality of life.
Research and Publications
- “Molecular Genetics of Thyroid Cancer”
- “Targeted Therapies in Thyroid Carcinoma”
- “Oncogenic Pathways in Thyroid Neoplasia”
Dr. James A. Fagin
Medical Oncologist
Cancer Treated:
- 1275 York Avenue, New York, NY 10065
- (212) 639-2000
Dr. James A. Fagin, originally from the University of Buenos Aires, Argentina, completed his residency at Hadassah University Hospital in Jerusalem before relocating to the United States. At MSKCC, Dr. Fagin has established himself as a foremost expert in the molecular genetics of thyroid cancer, contributing significantly to the development of targeted therapies. His groundbreaking research and numerous publications have earned him prestigious awards, including the Van Meter Award. Dr. Fagin is highly respected for his scientific achievements and his commitment to mentoring junior researchers and fellows in the field of endocrine oncology.